IGF1 and colonic neoplasm: With regard to the IGF/IGF-1R axis, treatment with EGCG showed decreased levels of IGF-1 and reduced IGF-1R activation, whereas the levels of IGFBP-3 were found to be increased in colon cancer cells [69].